Orciprenaline

Drug Status in USA : Approved
Drug Status in Canada : Approved

Indication : Why is this medication prescribed?

Chronic management of reversible airways. AV heart block and sinus bradycardia.

Contraindication: What are the special precautions to be followed?

Under following conditions, use of this medication is inadvisable. Its use should be withhold as it would cause harm to the patient
Cardiac arrhythmias.

Other Precaution to be observed while taking this medication

CV disease (e.g. arrhythmia, hypertension, CHF), DM, glaucoma, hyperthyroidism, hypokalaemia, seizure disorders. Pregnancy and lactation.

What are possible side effects of this medication ?

Tachycardia, nervousness, increased serum glucose, increase potassium levels, tremor, headache, dizziness, nausea, vomiting, angina, diarrhoea.

Drug Category/Class

  • Adrenergic beta-2 Receptor Agonists
  • Bronchodilator Agents
  • Tocolytic Agents
  • Respiratory System
  • Drugs for Obstructive Airway Diseases
  • Adrenergics, Inhalants
  • Adrenergics for Systemic Use
  • Non-Selective Beta-Adrenoreceptor Agonists
  • Beta2 Agonists
  • Sympathomimetics
  • Non-selective beta-adrenoreceptor agonists
Prescribed For the treatment of bronchospasm, chronic bronchitis, asthma, and emphysema.
Weight :211.2576
Structure Orciprenaline
Generic Drug Orciprenaline prescribed For the treatment of bronchospasm, chronic bronchitis, asthma, and emphysema.
Formula

C11H17NO3

Orciprenaline has 3 Brands listed


Alupent (0.5 mg)Alupent (10 mg)
Alupent (100 ml)

Search Generic Drugs alphabetically